CJC-1295 with DAC Research Peptide

CJC-1295 with DAC (Drug Affinity Complex) is a synthetic peptide studied for its role in growth hormone–related signaling and extended activity pathways. It has gained attention in peptide research due to its ability to interact with mechanisms involved in hormonal regulation and sustained biological activity. Its modified structure with DAC has made it a subject of interest in studies related to endocrine function, metabolic processes, and signaling stability.

Mechanism of Action

CJC-1295 with DAC is studied for its interaction with key biological pathways. It is associated with growth hormone–releasing hormone (GHRH) receptor activity, supporting research into pathways linked to hormonal signaling and metabolic regulation. The presence of DAC contributes to prolonged interaction with biological systems, allowing extended pathway activity and signaling duration. Through these mechanisms, CJC-1295 with DAC is explored for its potential applications in advanced peptide and endocrine research.

Product Specifications

Compound: CJC-1295 with DAC

Form: Lyophilized Powder

Purity: High-Purity Peptide Synthesis

Storage: Recommended storage at 2–8°C

Application: Research Use Only

Advanced Peptide Technology

Our peptides are produced using advanced synthesis techniques to ensure consistency, stability, and high-quality standards. Each batch undergoes strict quality control to support reliable and reproducible research applications.

Disclaimer

This product is intended strictly for research purposes only and is not intended for human consumption or medical use.